tiprankstipranks
Advertisement
Advertisement
BioNTech Halts Phase 2 mRNA Monotherapy Trial in Resected Colorectal Cancer After DSMB Review
PremiumCompany AnnouncementsBioNTech Halts Phase 2 mRNA Monotherapy Trial in Resected Colorectal Cancer After DSMB Review
4d ago
BioNTech drops 9% after ending Phase 2 colorectal cancer trial
Premium
The Fly
BioNTech drops 9% after ending Phase 2 colorectal cancer trial
4d ago
BioNTech to terminate Phase 2 monotherapy trial of cevumeran
Premium
The Fly
BioNTech to terminate Phase 2 monotherapy trial of cevumeran
4d ago
BioNTech Earnings Call: COVID Slide, Oncology Push
PremiumCompany AnnouncementsBioNTech Earnings Call: COVID Slide, Oncology Push
27d ago
BioNTech price target lowered to $130 from $135 at Evercore ISI
Premium
The Fly
BioNTech price target lowered to $130 from $135 at Evercore ISI
27d ago
BioNTech: Oncology Pipeline, Strong Leadership, and Cash Balance Support Buy Rating with Unchanged $135 Price Target
Premium
Ratings
BioNTech: Oncology Pipeline, Strong Leadership, and Cash Balance Support Buy Rating with Unchanged $135 Price Target
27d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100